Plain-English translation of NCT04706663 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This is a long-term research study that follows people with prostate cancer to better understand how specific genetic changes in their tumors affect how the disease develops and progresses. Researchers want to learn more about genetic mutations and other molecular characteristics that might help predict how aggressive someone's cancer is and which treatments might work best. By tracking your health over time, this study aims to identify new targets for future cancer therapies.
Prostate cancer is very common in men, but doctors still don't fully understand all of the genetic changes that cause it or make it more aggressive. While scientists have identified some important genetic mutations linked to prostate cancer, there are likely many more to discover. This study exists to fill that gap—by following patients like you over time, researchers hope to find new genetic markers that could lead to better, more personalized treatments.
You likely qualify if…
You likely don't qualify if…
You would join one of two groups based on your genetic testing results or how well you've responded to treatment. Over time, researchers will track your medical history, treatment outcomes, and disease progression through follow-up visits and reviews of your medical records. You may be asked to provide blood or tissue samples for genetic analysis. The study involves regular monitoring to understand how your cancer evolves, but you would continue your normal cancer care with your own doctors.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States